Cargando…
Gene expression profiling revealed novel mechanism of action of Taxotere and Furtulon in prostate cancer cells
BACKGROUND: Both Taxotere and Capecitabine have shown anti-cancer activity against various cancers including prostate cancer. In combination, Taxotere plus Capecitabine has demonstrated higher anti-cancer activity in advanced breast cancers. However, the molecular mechanisms of action of Taxotere an...
Autores principales: | Li, Yiwei, Hussain, Maha, Sarkar, Sarah H, Eliason, James, Li, Ran, Sarkar, Fazlul H |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548501/ https://www.ncbi.nlm.nih.gov/pubmed/15656911 http://dx.doi.org/10.1186/1471-2407-5-7 |
Ejemplares similares
-
Increased therapeutic potential of an experimental anti-mitotic inhibitor SB715992 by genistein in PC-3 human prostate cancer cell line
por: Davis, David A, et al.
Publicado: (2006) -
Role of BioResponse 3,3′-Diindolylmethane in the Treatment of Human Prostate Cancer: Clinical Experience
por: Li, Yiwei, et al.
Publicado: (2016) -
Antitumor Effects of Combining Docetaxel (Taxotere) with the Antivascular Action of Ultrasound Stimulated Microbubbles
por: Goertz, David E., et al.
Publicado: (2012) -
MicroRNA Targeted Therapeutic Approach for Pancreatic Cancer
por: Li, Yiwei, et al.
Publicado: (2016) -
Targeting Bone Remodeling by Isoflavone and 3,3′-Diindolylmethane in the Context of Prostate Cancer Bone Metastasis
por: Li, Yiwei, et al.
Publicado: (2012)